Bringing the fundamentals into focus…
Back to Tyra Biosciences, Inc.
How Tyra Biosciences, Inc. stacks up
TYRA · against 448 other Healthcare companies of similar size
Overall
39/ 100
Below the middle of the pack.
Ranked #322 of 449 · scores higher than 26% of peers
Bars: peers in each 10-point band of the overall score72 peers with an overall score of 30–39, including TYRA · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around TYRA| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 1 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 3 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 4 | 2.29T KRW (≈$1.6B) | 88 | 83 | 90 | 96 | 0 / 2 | |
| 5 | 12.3B CNY (≈$1.7B) | 85 | 83 | 86 | 99 | 0 / 2 | |
| 322 | 1.4B USD | 39 | 8 | — | 13 | 0 / 2 | |
| 322 | 1.2B USD | 39 | 38 | 76 | 36 | 2 / 2 | |
| 322 | 749M USD | 39 | 8 | 75 | 18 | 1 / 2 | |
| 322 | 994M USD | 39 | 8 | — | 18 | 0 / 2 | |
| 322 | 1.5B USD | 39 | 8 | — | 16 | 0 / 2 | |
| 333 | 7.1B CNY (≈$989M) | 38 | 51 | 17 | 48 | 1 / 2 | |
| 333 | 1.4B USD | 38 | 8 | — | 13 | 0 / 2 | |
| 333 | 1.6B USD | 38 | 8 | 95 | 18 | 2 / 2 | |
| 333 | 1.9B USD | 38 | 66 | 22 | 54 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score